← Back to Search

Other

Yamani-15/5 chemical solution for Peripheral Arterial Disease

Phase 1
Waitlist Available
Led By Houssam Farres, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up compared to baseline
Awards & highlights

Study Summary

This trial will test whether a new solution can help with vascular calcification in patients with severe peripheral arterial disease who are scheduled for limb amputation.

Eligible Conditions
  • Peripheral Arterial Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility
Secondary outcome measures
Safety as measured by the number of participants with treatment-related adverse events as assessed by Common Toxicity Criteria for Adverse Effects v4.0.

Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
Infusion of Yamani-15/5 chemical solution.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,213 Previous Clinical Trials
3,767,011 Total Patients Enrolled
4 Trials studying Peripheral Arterial Disease
280 Patients Enrolled for Peripheral Arterial Disease
Houssam Farres, MDPrincipal InvestigatorMayo Clinic
3 Previous Clinical Trials
92 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~0 spots leftby Apr 2025